Literature DB >> 17593542

Placental mesenchymal dysplasia associated with fetal overgrowth and mosaic deletion of the maternal copy of 11p15.5.

W P Robinson1, J Slee, N Smith, A Murch, S K Watson, W L Lam, D E McFadden.   

Abstract

Placentae with mesenchymal dysplasia (PMD) are typically larger than average and show cystic areas on ultrasonography. Fetal outcomes are variable and are often associated with growth restriction. However, enigmatically, some associated fetuses show signs of Beckwith-Wiedemann syndrome (BWS). PMD has recently been shown to result from androgenetic (complete paternal uniparental disomy) chimerism in the placenta in pregnancies that were associated with some fetal growth restriction. Cases of PMD associated with overgrowth have not previously been investigated molecularly. We present a case of focal PMD associated with a male fetus showing overgrowth with an enlarged heart, marked fetal ascites and intrauterine fetal death at 34 weeks, but no other BWS manifestations. Mosaicism for an unbalanced translocation leading to deletion of the maternal copy of the BWS region on 11p15.5 and partial duplication of 17q was observed in placenta, but not fetal samples. While the placental findings of PMD can be caused by an unbalanced dosage of genes in 11p15.5 alone, fetal growth parameters appear to depend on the underlying mechanism and likely also the level and distribution of abnormal cells. (c) 2007 Wiley-Liss, Inc.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17593542     DOI: 10.1002/ajmg.a.31800

Source DB:  PubMed          Journal:  Am J Med Genet A        ISSN: 1552-4825            Impact factor:   2.802


  5 in total

1.  Molecular and clinical findings and their correlations in Silver-Russell syndrome: implications for a positive role of IGF2 in growth determination and differential imprinting regulation of the IGF2-H19 domain in bodies and placentas.

Authors:  Kazuki Yamazawa; Masayo Kagami; Toshiro Nagai; Tatsuro Kondoh; Kazumichi Onigata; Katsuhiro Maeyama; Tomonobu Hasegawa; Yukihiro Hasegawa; Toshio Yamazaki; Seiji Mizuno; Yoko Miyoshi; Shinichiro Miyagawa; Reiko Horikawa; Kentaro Matsuoka; Tsutomu Ogata
Journal:  J Mol Med (Berl)       Date:  2008-07-08       Impact factor: 4.599

2.  Aberrant hypomethylation at imprinted differentially methylated regions is involved in biparental placental mesenchymal dysplasia.

Authors:  Saori Aoki; Ken Higashimoto; Hidenori Hidaka; Yasufumi Ohtsuka; Shigehisa Aoki; Hiroyuki Mishima; Koh-Ichiro Yoshiura; Kazuhiko Nakabayashi; Kenichiro Hata; Hitomi Yatsuki; Satoshi Hara; Takashi Ohba; Hidetaka Katabuchi; Hidenobu Soejima
Journal:  Clin Epigenetics       Date:  2022-05-17       Impact factor: 7.259

3.  Three-dimensional sonography of placental mesenchymal dysplasia and its differential diagnosis.

Authors:  Edi Vaisbuch; Roberto Romero; Juan Pedro Kusanovic; Offer Erez; Shali Mazaki-Tovi; Francesca Gotsch; Chong Jai Kim; Jung-Sun Kim; Lami Yeo; Sonia S Hassan
Journal:  J Ultrasound Med       Date:  2009-03       Impact factor: 2.153

Review 4.  A Challenging Diagnosis: Placental Mesenchymal Dysplasia-Literature Review and Case Report.

Authors:  Claudia Mehedintu; Francesca Frincu; Oana-Maria Ionescu; Monica Mihaela Cirstoiu; Maria Sajin; Maria Olinca; Elvira Bratila; Aida Petca; Andreea Carp-Veliscu
Journal:  Diagnostics (Basel)       Date:  2022-01-24

5.  Paternal Hemizygosity in 11p15 in Mole-like Conceptuses: Two Case Reports.

Authors:  Lone Sunde; Helle Lund; Neil J Sebire; Anni Grove; Rosemary A Fisher; Isa Niemann; Eigil Kjeldsen; Lotte Andreasen; Estrid Staehr Hansen; Anders Bojesen; Lars Bolund; Mette Nyegaard
Journal:  Medicine (Baltimore)       Date:  2015-11       Impact factor: 1.889

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.